Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

Rite Aid Corp. said Thursday that its fiscal first-quarter pharmacy sales got a boost from a new class of drug.

Ozempic and other weight-loss drugs boost pharmacy sales at Rite Aid

Rite Aid Corporation (RAC) Q1 2024 Earnings Call Transcript June 29, 2023 8:30 AM ET Company Participants Byron Purcell - Vice President, Investor Relations and Treasurer Elizabeth "Busy" Burr - Interim Chief Executive Officer Matt Schroeder - Executive Vice President and Chief Financial Officer Chris DuPaul - Chief Operating Officer of Elixir Conference Call Participants Elizabeth Anderson - Evercore ISI George Hill - Deutsche Bank Lisa Gill - J.P. Morgan Carla Casella - J.P.

Rite Aid Corporation (RAC) Q1 2024 Earnings Call Transcript

Although the revenue and EPS for Rite Aid (RAD) give a sense of how its business performed in the quarter ended May 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Compared to Estimates, Rite Aid (RAD) Q1 Earnings: A Look at Key Metrics

Rite Aid (RAD) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $1.49. This compares to loss of $0.60 per share a year ago.

Rite Aid (RAD) Reports Q1 Loss, Tops Revenue Estimates

Rite Aid reported a quarterly loss of more than $306 million as the drugstore chain grapples with the loss of customers from its pharmacy benefit business.

Rite Aid Loss Hits $306 Million As Troubles Mount

Rite Aid Corp.'s stock RAD, -4.40% rose 7.5% in premarket trade Thursday, after the drug store chain posted a narrower-than-expected loss for its fiscal first quarter and better-than-expected revenue. The Philadelphia-based company posted a net loss of $306.7 million, or $5.56 a share, for the quarter to June 3, wider than the loss of $110.2 million, or $2.03 a share, posted in the year-earlier period.

Rite Aid's stock soars 7.5% premarket after company posts narrower-than-expected loss and revenue beat

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) today reported operating results for its first fiscal quarter ended June 3, 2023. “Our first quarter results were driven by strong script growth, solid pharmacy margins and early progress with our turnaround program, which offset underperformance on front-end sales in the Retail Pharmacy Segment and a higher-than-expected medical loss ratio at Elixir Insurance,” said Elizabeth “Busy” Burr, interim chief executive officer. “To help.

Rite Aid Corporation Reports Fiscal 2024 First Quarter Results

Rite Aid Corp.'s stock RAD, -3.15% slid another 3.8% Wednesday to a fresh record low, bringing its five-day loss to 23%. The stock has been under pressure since a Bloomberg report last week that the company is working with banks and lawyers to reorganize its debt, which totals about $2.9 billion, the bulk of which comes due in 2025 and 2026.

Rite Aid's stock slides to fresh record low ahead of earnings due Thursday

Rite Aid Corp.'s stock tumbled 13% Tuesday to a record low, amid concerns prompted by a Bloomberg report last week that the company is working with banks and lawyers to reorganize its debt.

Rite Aid's stock slides to record low amid concerns about possible restructuring of $2.9 billion of debt

Rite Aid's (RAD) Q1 results are expected to reflect muted demand for flu immunizations and COVID-19 vaccines, the adverse impacts of closed stores and reduced Elixir insurance memberships.

Things Likely to Decide Rite Aid's (RAD) Fate in Q1 Earnings

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid Corporation (NYSE: RAD) will release financial results for its Fiscal 2024 First Quarter, which ended June 3, 2023, on Thursday, June 29, 2023. The company will hold an analyst call at 8:30 a.m. ET with remarks by Rite Aid's management team. The call will be broadcast at https://investors.riteaid.com. The telephone replay will be available beginning at 12:00 p.m. ET on Thursday, June 29, 2023, through 11:59 p.m. ET on July 29, 2023. To access the replay o.

Rite Aid to Release First Quarter Results on June 29

AMC Entertainment

Mullen Automotive

Newegg Commerce

Paramount Group

Vroom

Exela Technologies

“Price is what you pay, value is what you get.” This famed Warren Buffett investing maxim can serve you well when determining whether a penny stock (stock trading for $5 per share or less) is worthy of a buy, or if it is one of the penny stocks to sell.

7 Penny Stocks to Sell in June Before They Crash and Burn

PHILADELPHIA--(BUSINESS WIRE)--Rite Aid (NYSE: RAD) today announced that Thomas Sabatino has joined the company as Executive Vice President and Chief Legal Officer. Sabatino will play a pivotal role in the company's growth strategy to help create meaningful customer, client, and member experiences for millions of Americans. As Chief Legal Officer, he will oversee the organization's legal affairs, including enterprise risk management, compliance, regulatory affairs, and privacy. “As we continue.

Rite Aid Names Thomas Sabatino Chief Legal Officer

PHILADELPHIA--(BUSINESS WIRE)--Today national drug store chain Rite Aid announced the launch of RYSHI™ – its exclusive collection of clean beauty and personal care essentials designed to let the real you shine through. Spanning across multiple categories, RYSHI™ products offer better-for-you ingredients at an accessible price point so customers can conveniently build their beauty toolkit at their neighborhood Rite Aid. The full collection offers a vast range of products so customers can find an.

Rite Aid Empowers Customers to Be Themselves with Launch of RYSHI™ Beauty and Personal Care Essentials

Blue Apron

Clover Health Investments

FuboTV

MannKind

While there are plenty of bargains to buy among penny stocks, there are also a good amount of overvalued penny stocks to sell. While significantly lower-priced now than they were at their respective high water-marks, many of these stocks are hardly bargains, trading at valuations unsustainable relative to their current operating performance.

7 Overvalued Penny Stocks to Sell Before June 2023

PHILADELPHIA--(BUSINESS WIRE)--Elixir, a pharmacy benefit management company owned by Rite Aid (NYSE: RAD), has announced details of the next release of its Laker Software technology platform. The upcoming enhancements include new automated workflows, a customer service tool and modernization of the user interface. "Already a leader in the industry, Laker Software is going from good to great,” said Jeff Mallad, VP, PBM Technology Sales for Elixir. "Elixir's technology platform is one of the fas.

Elixir announces the next wave of innovation for pharmacy benefits technology platform

NEW YORK , May 19, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rite Aid Corporation - RAD

NEW YORK , May 19, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Rite Aid Corporation (NYSE: RAD). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/rite-aid-class-action-loss-submission-form/?id=39587&from=4 The lawsuit seeks to recover losses for shareholders who purchased Rite Aid between April 26, 2018 and March 13, 2023.

RAD SHAREHOLDER ALERT: Jakubowitz Law Reminds Rite Aid Shareholders of a Lead Plaintiff Deadline of May 19, 2023

LOS ANGELES, CA / ACCESSWIRE / May 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE:RAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 26, 2018 and March 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before May 19, 2023.

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

NEW YORK , May 18, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rite Aid investors who were adversely affected by alleged securities fraud between April 26, 2018 and March 13, 2023.

RAD LAWSUIT ALERT: Levi & Korsinsky Notifies Rite Aid Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK , May 17, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rite Aid Corporation. Shareholders who purchased shares of RAD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rite Aid Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 19, 2023 - (NYSE: RAD)

LOS ANGELES, CA / ACCESSWIRE / May 16, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE:RAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 26, 2018 and March 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before May 19, 2023.

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

NEW YORK , May 16, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rite Aid Corporation (NYSE: RAD) alleging that the Company violated federal securities laws. Class Period: April 26, 2018 to March 13, 2023 Lead Plaintiff Deadline: May 19, 2023 No obligation or cost to you.

RAD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 19, 2023 in the Class Action Filed on Behalf of Rite Aid Corporation Shareholders

NEW YORK , May 15, 2023 /PRNewswire/ -- Attention Rite Aid Corporation ("Rite Aid") (NYSE: RAD) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between April 26, 2018 and March 13, 2023. If you suffered a loss on your investment in Rite Aid, contact us about potential recovery by using the link below.

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rite Aid Investors of a Lead Plaintiff Deadline of May 19, 2023

LOS ANGELES, CA / ACCESSWIRE / May 10, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE:RAD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 26, 2018 and March 13, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before May 19, 2023.

News for Rite Aid Stock (RAD)